These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1814653

  • 1. Follicle stimulating hormone stimulates the production of gonadotrophin surge attenuating factor (GnSAF) in vivo.
    Messinis IE, Hirsch P, Templeton AA.
    Clin Endocrinol (Oxf); 1991 Nov; 35(5):403-7. PubMed ID: 1814653
    [Abstract] [Full Text] [Related]

  • 2. Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women.
    Messinis IE, Lolis D, Papadopoulos L, Tsahalina T, Papanikolaou N, Seferiadis K, Templeton AA.
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):45-50. PubMed ID: 8348707
    [Abstract] [Full Text] [Related]

  • 3. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle.
    Messinis IE, Lolis D, Zikopoulos K, Milingos S, Kollios G, Seferiadis K, Templeton AA.
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):169-75. PubMed ID: 8849571
    [Abstract] [Full Text] [Related]

  • 4. Activity of gonadotrophin surge-attenuating factor during the luteal phase in superovulated women.
    Messinis IE, MacTavish A, Templeton AA.
    J Reprod Fertil; 1993 Jan; 97(1):271-5. PubMed ID: 8464020
    [Abstract] [Full Text] [Related]

  • 5. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE, Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K, Lolis D.
    Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of gonadotrophin release and reserve in superovulated women by gonadotrophin surge attenuating factor (GnSAF).
    Messinis IE, Templeton A.
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):259-63. PubMed ID: 1908754
    [Abstract] [Full Text] [Related]

  • 7. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 8. Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone.
    Messinis IE, Lolis D, Zikopoulos K, Tsahalina E, Seferiadis K, Templeton AA.
    Hum Reprod; 1994 Aug; 9(8):1437-41. PubMed ID: 7989501
    [Abstract] [Full Text] [Related]

  • 9. In-vivo bioactivity of gonadotrophin surge attenuating factor (GnSAF).
    Messinis IE, Templeton A.
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):213-8. PubMed ID: 2121393
    [Abstract] [Full Text] [Related]

  • 10. Effect of an increase in FSH on the production of gonadotrophin-surge-attenuating factor in women.
    Messinis IE, Lolis D, Zikopoulos K, Tsahalina E, Seferiadis K, Templeton AA.
    J Reprod Fertil; 1994 Aug; 101(3):689-95. PubMed ID: 7966027
    [Abstract] [Full Text] [Related]

  • 11. Attenuating activity of the ovary on LH response to GnRH during the follicular phase of the cycle.
    Dimitraki M, Messini CI, Dafopoulos K, Gioka T, Koutlaki N, Garas A, Georgoulias P, Messinis IE.
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):439-43. PubMed ID: 23909480
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles.
    Martinez F, Barri PN, Coroleu B, Tur R, Sorsa-Leslie T, Harris WJ, Groome NP, Knight PG, Fowler PA.
    Hum Reprod; 2002 Mar; 17(3):634-40. PubMed ID: 11870115
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20 years of research?
    Fowler PA, Sorsa-Leslie T, Harris W, Mason HD.
    Reproduction; 2003 Dec; 126(6):689-99. PubMed ID: 14748688
    [Abstract] [Full Text] [Related]

  • 18. Changes in pituitary response to gonadotropin-releasing hormone following bilateral ovariectomy in women treated with follicle-stimulating hormone.
    Messinis IE, Milingos S, Kollios G, Seferiadis K, Papanikolaou N, Lolis D.
    Gynecol Endocrinol; 1996 Dec; 10(6):383-90. PubMed ID: 9032564
    [Abstract] [Full Text] [Related]

  • 19. The ovarian modulation of gonadotrophin releasing hormone-induced luteinizing hormone secretion in women.
    Fowler PA, Templeton A, Messinis IE.
    Hum Reprod; 1993 Nov; 8 Suppl 2():112-6. PubMed ID: 8276943
    [Abstract] [Full Text] [Related]

  • 20. Higher gonadotrophin surge-attenuating factor bioactivity is found in small follicles from superovulated women.
    Fowler PA, Fraser M, Cunningham P, Knight PG, Byrne B, McLaughlin EA, Wardle PG, Hull MG, Templeton A.
    J Endocrinol; 1994 Oct; 143(1):33-44. PubMed ID: 7964320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.